Rausing laboratory of Lund - Tumor section
51 – 60 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma
(
- Contribution to journal › Article
-
Mark
Anti-C1-inactivator treatment of glioblastoma
(
- Contribution to journal › Article
-
Mark
The effect of prostate motion during hypofractionated radiotherapy can be reduced by using flattening filter free beams
(
- Contribution to journal › Article
- 2017
-
Mark
C1-inactivator is upregulated in glioblastoma
(
- Contribution to journal › Article
-
Mark
Exploration of Electro-Enhanced-Chemotherapy II. : Uptake of radioactive tracer in rat Muscle tissue at 6 and 24 hours after applied electric pulses of 1000 V/cm field-strength, 100 micro-s pulse-length, and various number of pulses.
(
- Contribution to journal › Article
-
Mark
T Cell Activation Pathways : B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
(
- Contribution to journal › Article
-
Mark
A clinical distance measure for evaluating treatment plan quality difference with Pareto fronts in radiotherapy
(
- Contribution to journal › Article
- 2016
-
Mark
ITPP treatment of RG2 glioblastoma in a rat model
(
- Contribution to journal › Article
-
Mark
Maintenance of the E.coli dcm Methylation of the CMV Promoter, in Contrast to Hypomethylation of the Recognition Sequence of Transcription Factor NFkB in Transfected GBM Cells
(
- Contribution to journal › Article
- 2015
-
Mark
Effect of Blockade of Indoleamine 2, 3-dioxygenase in Conjunction with Single Fraction Irradiation in Rat Glioma
(
- Contribution to journal › Article